Sarepta Therapeutics, Inc. (SRPT)
13.51
-0.66
(-4.66%)
USD |
NASDAQ |
Nov 20, 15:00
Sarepta Therapeutics 30-Day Average Daily Volume : 2.419M for Nov. 19, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| November 19, 2026 | 2.419M |
| November 18, 2026 | 2.468M |
| November 17, 2026 | 2.501M |
| November 16, 2026 | 2.511M |
| November 13, 2026 | 2.517M |
| November 12, 2026 | 2.558M |
| November 11, 2026 | 2.580M |
| November 10, 2026 | 2.578M |
| November 09, 2026 | 2.512M |
| November 06, 2026 | 2.505M |
| November 05, 2026 | 2.492M |
| November 04, 2026 | 2.515M |
| November 03, 2026 | 2.591M |
| November 02, 2026 | 2.618M |
| October 30, 2026 | 2.637M |
| October 29, 2026 | 2.803M |
| October 28, 2026 | 2.850M |
| October 27, 2026 | 2.888M |
| October 26, 2026 | 2.899M |
| October 23, 2026 | 2.926M |
| October 22, 2026 | 2.944M |
| October 21, 2026 | 2.976M |
| October 20, 2026 | 3.047M |
| October 19, 2026 | 3.144M |
| October 16, 2026 | 3.165M |
| Date | Value |
|---|---|
| October 15, 2026 | 2.929M |
| October 14, 2026 | 2.955M |
| October 13, 2026 | 2.951M |
| October 12, 2026 | 2.916M |
| October 09, 2026 | 2.927M |
| October 08, 2026 | 3.091M |
| October 07, 2026 | 3.054M |
| October 06, 2026 | 3.015M |
| October 05, 2026 | 2.971M |
| October 02, 2026 | 2.954M |
| October 01, 2026 | 2.966M |
| September 30, 2026 | 3.034M |
| September 29, 2026 | 3.021M |
| September 28, 2026 | 3.033M |
| September 25, 2026 | 3.010M |
| September 24, 2026 | 3.020M |
| September 23, 2026 | 3.013M |
| September 22, 2026 | 2.988M |
| September 21, 2026 | 3.005M |
| September 18, 2026 | 3.048M |
| September 17, 2026 | 3.013M |
| September 16, 2026 | 3.031M |
| September 15, 2026 | 3.043M |
| September 14, 2026 | 3.085M |
| September 11, 2026 | 3.132M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Beam Therapeutics, Inc. | 2.163M |
| Moderna, Inc. | 14.61M |
| Rocket Pharmaceuticals, Inc. | 1.904M |
| Intellia Therapeutics, Inc. | 5.158M |
| Twist Bioscience Corp. | 2.465M |